Nikhil Lalwani Sells ANI Pharmaceuticals Stock
2026-05-13SEC Filing 4 (0001822629-26-000011)
On May 11, 2026, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc., reported the sale of 55,000 shares of common stock. The transactions occurred at a weighted average price of $77.57 per share, with individual sales ranging from $76.21 to $80.38. Following these sales, Mr. Lalwani directly owns 349,889 shares of the company's stock.